Current treatment of cutaneous lupus erythematosus.
Cutaneous lupus erythematosus has a variety of clinical presentations, but treatment is similar for the different forms. The antimalarials remain the cornerstone of treatment because of their effectiveness and safety. Optimal use of the antimalarials as well as alternative therapy options are discussed.
Werth
V
V
Department of Dermatology, University of Pennsylvania, USA.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D008179:Lupus Erythematosus, Discoid / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011796:Quinacrine / Q000008:administration & dosage / Q000009:adverse effects; D012871:Skin Diseases / Q000175:diagnosis; D013473:Sunscreening Agents / Q000008:administration & dosage; D014466:Ultraviolet Rays / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D013473:Sunscreening Agents; D011796:Quinacrine; D001241:Aspirin